A combined NMR and molecular dynamics simulation study to determine the conformational properties of rat/mouse 35-55 myelin oligodendrocyte glycoprotein epitope implicated in the induction of experimental autoimmune encephalomyelitis

References

• Albouz-Abo, S., Wilson, J. C., Bernard, C. C. A., & von Itzstein, M. (1997). A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35–55. European Journal of Biochemistry, 246, 59–70. doi:10.1111/j.1432-1033.1997.t01-2-00059.x
   PubMedGoogle Scholar
• Breithaupt, C., Schubart, A., Zander, H., Skerra, A., Huber, R., Linington, C., & Jacob, U. (2003). Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences, USA, 100, 9446–9451. doi:10.1073/pnas.1133443100
   PubMed Web of Science ®Google Scholar
• Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J. M., & Linington, C. (1989). Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. Journal of Neurochemistry, 52, 296–304. doi:10.1111/j.1471-4159.1989.tb10930.x
   PubMed Web of Science ®Google Scholar
• Gabibov, A. G., Belogurov, A. A., Jr, Lomakin, Y. A., Zakharova, M. Y., Avakyan, M. E., Dubrovskaya, V. V., … Tikunova, N. V. (2011). Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB Journal, 25, 4211–4221. doi:10.1096/fj.11-190769
   PubMed Web of Science ®Google Scholar
• Gardinier, M. V., Amiguet, P., Linington, C., & Matthieu, J. M. (1992). Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. Journal of Neuroscience Research, 33, 177–187. doi:10.1002/jnr.490330123
   PubMed Web of Science ®Google Scholar
• Hemmer, B., Cepok, S., Zhou, D., & Sommer, N. (2004). Multiple sclerosis – a coordinated immune attack across the blood brain barrier. Current Neurovascular Research, 1, 141–150. doi:10.2174/1567202043480152
   PubMed Web of Science ®Google Scholar
• Johns, T. G., & Bernard, C. C. (1999). The structure and function of myelin oligodendrocyte glycoprotein. Journal of Neurochemistry, 72, 1–9. doi:10.1046/j.1471-4159.1999.0720001.x
   PubMed Web of Science ®Google Scholar
• Kordopati, G. G., Tselios, T. V., Kellici, T., Merzel, F., Mavromoustakos, T., Grdadolnik, S. G., & Tsivgoulis, G. M. (2015). A novel synthetic luteinizing hormone-releasing hormone (LHRH) analogue coupled with modified beta-cyclodextrin: insight into its intramolecular interactions. Biochimica et Biophysica Acta, 1850, 159–168. doi:10.1016/j.bbagen.2014.10.017
   PubMed Web of Science ®Google Scholar
• Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., … Wekerle, H. (1993). T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. European Journal of Immunology, 23, 1364–1372. doi:10.1002/eji.1830230627
   PubMed Web of Science ®Google Scholar
• Martin, R., & McFarland, H. F. (1995). Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Critical Reviews in Clinical Laboratory Sciences, 32, 121–182. doi:10.3109/10408369509084683
   PubMed Web of Science ®Google Scholar
• Mendel, I., Kerlero de Rosbo, N., & Ben-Nun, A. (1995). A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. European Journal of Immunology, 25, 1951–1959. doi:10.1002/eji.1830250723
   PubMed Web of Science ®Google Scholar
• Oliver, A. R., Lyon, G. M., & Ruddle, N. H. (2003). Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. Journal of Immunology, 171, 462–468. doi:10.4049/jimmunol.171.9.4934
   PubMed Web of Science ®Google Scholar
• Potamitis, C., Matsoukas, M. T., Tselios, T., Mavromoustakos, T., & Golic Grdadolnik, S. (2011). Conformational analysis of the MuBetaRho83-99 (Phe91) and MuBetaRho83-99 (Tyr91) peptide analogues and study of their interactions with the HLA-DR2 and human TCR receptors by using molecular dynamics. Journal of Computer-Aided Molecular Design, 25, 837–853. doi:10.1007/s10822-011-9467-4
   PubMed Web of Science ®Google Scholar
• Tselios, T., Aggelidakis, M., Tapeinou, A., Tseveleki, V., Kanistras, I., Gatos, D., & Matsoukas, J. (2014). Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: Inhibition of chronic experimental autoimmune encephalomyelitis in mice. Molecules, 19, 17968–17984. doi:10.3390/molecules191117968
   PubMed Web of Science ®Google Scholar
• Tseveleki, V., Tselios, T., Kanistras, I., Koutsoni, O., Karamita, M., Vamvakas, S.-S., … Probert, L. (2015). Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Experimental Neurology, 267, 254–267. doi:10.1016/j.expneurol.2014.10.019
   PubMed Web of Science ®Google Scholar